{"id":"https://openalex.org/W2017565505","doi":"https://doi.org/10.1016/s0197-2456(96)00089-x","title":"Use of Irwin's restricted mean as an index for comparing survival in different treatment groups\u2014Interpretation and power considerations","display_name":"Use of Irwin's restricted mean as an index for comparing survival in different treatment groups\u2014Interpretation and power considerations","alternate_titles":[],"publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W2017565505","doi":"https://doi.org/10.1016/s0197-2456(96)00089-x","mag":"2017565505","pmid":"https://pubmed.ncbi.nlm.nih.gov/9129859"},"language":"en","primary_location":{"id":"doi:10.1016/s0197-2456(96)00089-x","doi":"https://doi.org/10.1016/s0197-2456(96)00089-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0197-2456(96)00089-x","pdf_url":null,"source":{"id":"https://openalex.org/S84962792","display_name":"Controlled Clinical Trials","issn_l":"0197-2456","issn":["0197-2456","1879-050X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled Clinical Trials","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017565505"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038171309","display_name":"Theodore G Karrison","orcid":"https://orcid.org/0009-0009-8641-5111","observed_orcids":["https://orcid.org/0009-0009-8641-5111"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Theodore G. Karrison","raw_affiliation_strings":["Department of Medicine, University of Chicago, IL 60637, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Chicago, IL 60637, USA","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5038171309"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":1.6142,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.82349038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"18","issue":"2","first_page":"151","last_page":"167"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8622999787330627,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8622999787330627,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13500","display_name":"Probability and Statistical Research","score":0.07779999822378159,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10136","display_name":"Statistical Methods and Inference","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mean-survival-time","display_name":"mean survival time","score":0.7039999961853027},{"id":"https://openalex.org/keywords/censored-survival-data","display_name":"censored survival data","score":0.7799999713897705},{"id":"https://openalex.org/keywords/treatment-comparison","display_name":"treatment comparison","score":0.5289999842643738},{"id":"https://openalex.org/keywords/power-analysis","display_name":"power analysis","score":0.550000011920929},{"id":"https://openalex.org/keywords/non-proportional-hazards","display_name":"non-proportional hazards","score":0.8500000238418579},{"id":"https://openalex.org/keywords/log-rank-test","display_name":"log-rank test","score":0.75},{"id":"https://openalex.org/keywords/wilcoxon-test","display_name":"Wilcoxon test","score":0.8650000095367432},{"id":"https://openalex.org/keywords/piecewise-exponential-model","display_name":"piecewise exponential model","score":0.9079999923706055},{"id":"https://openalex.org/keywords/covariate-adjustment","display_name":"covariate adjustment","score":0.8920000195503235},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":0.968999981880188},{"id":"https://openalex.org/keywords/randomized-controlled-trials","display_name":"randomized controlled trials","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.7648552656173706},{"id":"https://openalex.org/C137668524","wikidata":"https://www.wikidata.org/wiki/Q189813","display_name":"Censoring (clinical trials)","level":2,"score":0.7340863943099976},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.675194263458252},{"id":"https://openalex.org/C185429906","wikidata":"https://www.wikidata.org/wiki/Q1130160","display_name":"Estimator","level":2,"score":0.6157634258270264},{"id":"https://openalex.org/C33114746","wikidata":"https://www.wikidata.org/wiki/Q4672282","display_name":"Accelerated failure time model","level":3,"score":0.6043829321861267},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.5717399716377258},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.5664420127868652},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.531586229801178},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.5274921655654907},{"id":"https://openalex.org/C206041023","wikidata":"https://www.wikidata.org/wiki/Q1751970","display_name":"Wilcoxon signed-rank test","level":3,"score":0.5087166428565979},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5006937980651855},{"id":"https://openalex.org/C102366305","wikidata":"https://www.wikidata.org/wiki/Q1097688","display_name":"Nonparametric statistics","level":2,"score":0.43973442912101746},{"id":"https://openalex.org/C12868164","wikidata":"https://www.wikidata.org/wiki/Q1424533","display_name":"Mann\u2013Whitney U test","level":2,"score":0.11634209752082825}],"mesh":[{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008105","descriptor_name":"Liver Cirrhosis, Biliary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008105","descriptor_name":"Liver Cirrhosis, Biliary","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010396","descriptor_name":"Penicillamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0197-2456(96)00089-x","doi":"https://doi.org/10.1016/s0197-2456(96)00089-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0197-2456(96)00089-x","pdf_url":null,"source":{"id":"https://openalex.org/S84962792","display_name":"Controlled Clinical Trials","issn_l":"0197-2456","issn":["0197-2456","1879-050X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled Clinical Trials","raw_type":"journal-article"},{"id":"pmid:9129859","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9129859","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled clinical trials","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1969500349","https://openalex.org/W1979300931","https://openalex.org/W1986705681","https://openalex.org/W2005526508","https://openalex.org/W2025321408","https://openalex.org/W2034094574","https://openalex.org/W2038252730","https://openalex.org/W2042296356","https://openalex.org/W2048332105","https://openalex.org/W2057968703","https://openalex.org/W2077050546","https://openalex.org/W2095002555","https://openalex.org/W2104452301","https://openalex.org/W2106147539","https://openalex.org/W2139895288","https://openalex.org/W2139984188","https://openalex.org/W2141861294","https://openalex.org/W2327667520","https://openalex.org/W2327954903","https://openalex.org/W2328829411","https://openalex.org/W2339379332","https://openalex.org/W2429298507","https://openalex.org/W2794027193","https://openalex.org/W2796700885","https://openalex.org/W2796930440","https://openalex.org/W2995133996","https://openalex.org/W3041047318","https://openalex.org/W3147894994","https://openalex.org/W4236640235","https://openalex.org/W4238237534","https://openalex.org/W4294570726"],"related_works":["https://openalex.org/W2048332105","https://openalex.org/W2072013249","https://openalex.org/W4390956657","https://openalex.org/W4408996439","https://openalex.org/W3103690997","https://openalex.org/W2802003196","https://openalex.org/W119562111","https://openalex.org/W3015536182","https://openalex.org/W2793899037","https://openalex.org/W3132156846"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017565505","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
